Latest Cancer Research Stories
Lung-MAP Trial Will Test Five Investigational Approaches, Including Amgen's Rilotumumab, an Investigational Fully Human Monoclonal Antibody THOUSAND OAKS, Calif., June 16, 2014 /PRNewswire/
The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,
Research grant recipient will be studying the contribution of the polycomb repressive complex (PRC2) towards gastric cancer progression. FT.
FLEMINGTON, N.J., June 11, 2014 /PRNewswire/ -- According to the American Cancer Society, lung cancer is the second most common cancer among men and women and the leading cause of death in the
POINT ROBERTS, Wash.
--Study in Nature Genetics Used PGDx Exome Analysis to Identify Previously Unknown Mutation with Potential as New Drug Target for Lethal Childhood Brain Cancer-- BALTIMORE, June
Barbara and Edward Netter awarded prestigious distinction by the American Society of Gene and Cell Therapy. Washington, DC (PRWEB) June 05, 2014 Barbara
LONDON, June 5, 2014 /PRNewswire/ -- Elekta (NSE: EKTAb) and Royal Philips (NYSE: PHG, AEX: PHIA) announced today that The Institute of Cancer Research, London, a world-leading cancer research
The Pancreatic Cancer Action Network, Rising Tide Foundation for Clinical Research, and Gateway for Cancer Research Award More Than $1.2 Million in Grants MANHATTAN BEACH, Calif.,
WASHINGTON, June 3, 2014 /PRNewswire-USNewswire/ -- Physician researchers from Georgetown Lombardi Comprehensive Cancer Center, in Washington, D.C., and John Theurer Cancer Center (JTCC) in
- totally perplexed and mixed up.